TissueCypher - Barrett's Esophagus’ Post

Castle Biosciences' TissueCypher® test can offer patients with Barrett's esophagus a clearer picture of their risk of developing esophageal cancer, which is the 8th most common form of cancer worldwide and the 6th leading cause of cancer death (due in part to late diagnoses). Learn more about how TissueCypher can help (via USA TODAY and Mediaplanet USA): https://lnkd.in/gMBycc73

Story from Castle Biosciences: A Game-Changing Test in the Fight Against Esophageal Cancer

Story from Castle Biosciences: A Game-Changing Test in the Fight Against Esophageal Cancer

usatoday.com

To view or add a comment, sign in

Explore topics